Keyword: UC San Francisco
Livongo and the University of California, San Francisco, launched a randomized, controlled trial that will recruit 300 adults with Type 2 diabetes.
A UCSF spinoff is working with GlaxoSmithKline to develop a drug to target a common mutation in glioblastoma.
A new electroporation-based CRISPR-Cas9 method could improve gene editing for CAR-T and other cell therapies.
UC San Francisco scientists used a process called synNotch signaling to prompt individual cells to form tissue structures.
UCSF researchers are figuring out how to set prostate cancer cells on a path to self-destruction by interfering with a process that controls protein synthesis.
Biotech discoveries over the past week included new way to harness the lethal power of Huntington’s disease and llama antibodies sans llamas.
The week’s biotech discoveries include an insulin-related gene mutation and the news that previously ignored brain structures could govern obesity.
Scientists at the University of California, San Francisco are recreating early development, then leaving it up to cells to fold themselves into complex human tissues.
A new form of CRISPR/Cas9 activates specific genes without making breaks in the DNA, which can reduce harmful side effects.
UCSF scientists are testing a therapeutic vaccine that can prompt the immune system to launch an attack against a cancer.